Lineage Cell Therapeutics (LCTX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov7

Lineage Cell Therapeutics released FY2025 9 Months Earnings on November 6 After-Market EST, with actual revenue of USD 7.948 M and EPS of USD -0.2818

00:00

Lineage Cell Therapeutics released FY2025 Q3 earnings on November 6 After-Market EST, actual revenue USD 3.681 M (forecast USD 2.295 M), actual EPS USD -0.1301 (forecast USD -0.0257)

00:00

Oct30

Lineage Cell Therapeutics to Release FY2025 Q3 Earnings on November 6 After-Market EST, Forecast Revenue USD 2.295 M, EPS USD -0.0257

00:10

Aug12

Lineage Cell Therapeutics released FY2025 Q2 earnings on August 12 After-Market EST, actual revenue USD 2.765 M (forecast USD 1.473 M), actual EPS USD -0.1334 (forecast USD -0.0285)

23:00

Lineage Cell Therapeutics released FY2025 Semi-Annual earnings on August 12 After-Market EST, actual revenue USD 4.267 M (forecast USD 3.42 M), actual EPS USD -0.1522 (forecast USD -0.03)

23:00

Aug5

Lineage Cell Therapeutics to Release FY2025 Q2 Earnings on August 12 After-Market EST, Forecast Revenue USD 1.473 M, EPS USD -0.0285

00:06